Thomas D. Salus's most recent trade in Lifecore Biomedical Inc was a trade of 370,000 Performance-Based Restricted Stock Units done . Disclosure was reported to the exchange on April 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 370,000 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 210,000 | 210,000 | - | - | Incentive Stock Option (Right to Buy) | |
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 170,000 | 215,000 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Thomas D. Salus | Chief Legal & Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 45,000 | 45,000 (0%) | 0% | - | Common Stock |